Exercise for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exercise can benefit people with lung or esophageal cancer who are receiving radiation treatment, along with their family caregivers. Participants engage in up to 15 exercise sessions over five to six weeks, focusing on resistance, aerobic, and flexibility training. The goal is to assess the feasibility and acceptability of this Dyadic Exercise Program. Suitable candidates include those diagnosed with non-small cell lung or esophageal cancer, who are undergoing specific radiation treatment, and have a family caregiver willing to participate in the exercise sessions. As an unphased trial, this study provides a unique opportunity to enhance understanding of the benefits of exercise for cancer patients and their caregivers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise protocol is safe for lung cancer patients and their caregivers?
Research has shown that exercise programs for people with lung cancer are safe and effective. In one study, both patients with lung cancer and their caregivers found these programs acceptable, with no major safety issues reported. Another study found that exercise can help reduce the fatigue many cancer survivors experience. This indicates that exercise is not only safe but also enhances patient well-being. Overall, current evidence suggests that exercise programs are well-received and improve quality of life.12345
Why are researchers excited about this trial?
Researchers are excited about the Dyadic Exercise Program for lung cancer patients because it focuses on enhancing patients' physical fitness during radiation treatment, which is not a typical part of standard care. Unlike traditional treatments that mainly focus on chemotherapy, radiation, and surgery, this program combines resistance, aerobic, and flexibility exercises to improve patients' overall strength and well-being. This approach could potentially help patients better tolerate their radiation therapy, reduce side effects, and improve their quality of life.
What evidence suggests that this exercise protocol is effective for lung cancer?
Research has shown that exercise programs involving both patients and caregivers can enhance the quality of life and mental health of cancer patients. Studies indicate these programs help reduce cancer-related fatigue and improve physical abilities. In this trial, participants will engage in a Dyadic Exercise Program, which includes up to 15 exercise sessions during their 5-6 week radiation treatment period. For lung cancer patients, exercise has been linked to better treatment adherence and increased social support. These activities can also improve communication and reduce stress for both patients and caregivers. Overall, evidence suggests that exercising together could effectively support lung cancer patients during treatment.23678
Who Is on the Research Team?
Kathrin Milbury, MA,PHD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for lung cancer patients receiving thoracic radiotherapy and their family caregivers. Specific eligibility criteria are not detailed, but typically participants must be medically stable to engage in exercise and willing to participate together.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants undergo thoracic radiation treatment
Exercise Program
Participants and caregivers engage in a dyadic exercise program including resistance, aerobic, and flexibility training
Follow-up
Participants are monitored for safety and effectiveness after treatment, including quality of life assessments
What Are the Treatments Tested in This Trial?
Interventions
- Dyadic Exercise Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor